Acinetobacter baumannii subunit vaccines: recent progress and challenges
YT Lau, HS Tan - Critical reviews in microbiology, 2024 - Taylor & Francis
Acinetobacter baumannii is a Gram-negative, opportunistic pathogen that causes
nosocomial infection with a high mortality rate in immunocompromised individuals. With the …
nosocomial infection with a high mortality rate in immunocompromised individuals. With the …
First steps towards a vaccine against Acinetobacter baumannii
M Garcia-Quintanilla, MR Pulido… - Current …, 2013 - ingentaconnect.com
Acinetobacter baumannii has become an important cause of human infections, most notably
in the hospital setting. In addition, the global dissemination of multidrug resistant strains has …
in the hospital setting. In addition, the global dissemination of multidrug resistant strains has …
Subunit vaccines for Acinetobacter baumannii
N Yang, X Jin, C Zhu, F Gao, Z Weng, X Du… - Frontiers in …, 2023 - frontiersin.org
Acinetobacter baumannii is a gram-negative bacterium and a crucial opportunistic pathogen
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …
in hospitals. A. baumannii infection has become a challenging problem in clinical practice …
Recent Advances in the Pursuit of an Effective Acinetobacter baumannii Vaccine
PS Gellings, AA Wilkins, LA Morici - Pathogens, 2020 - mdpi.com
Acinetobacter baumannii has been a major cause of nosocomial infections for decades. The
absence of an available vaccine coupled with emerging multidrug resistance has prevented …
absence of an available vaccine coupled with emerging multidrug resistance has prevented …
Current advances and challenges in the development of Acinetobacter vaccines
W Chen - Human vaccines & immunotherapeutics, 2015 - Taylor & Francis
Acinetobacter baumannii is a major cause of healthcare-associated infections worldwide
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
with high morbidity and mortality. The clinical treatment of A. baumannii infections has …
Mapping Global Prevalence of Acinetobacter baumannii and Recent Vaccine Development to Tackle It
Acinetobacter baumannii is a leading cause of nosocomial infections that severely threaten
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
public health. The formidable adaptability and resistance of this opportunistic pathogen have …
Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii
W Huang, Y Yao, S Wang, Y Xia, X Yang, Q Long… - Scientific reports, 2016 - nature.com
A. baumannii infections are becoming more and more serious health issues with rapid
emerging of multidrug and extremely drug resistant strains, and therefore, there is an urgent …
emerging of multidrug and extremely drug resistant strains, and therefore, there is an urgent …
Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development
ABSTRACT In 2017, the World Health Organization (WHO) named A. baumannii as one of
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …
[HTML][HTML] Vaccines for Acinetobacter baumannii: thinking “out of the box”
We are indeed fortunate that modern medicine continues to offer advancements that
promise better and longer lives. Delivering on that promise depends on our ability to …
promise better and longer lives. Delivering on that promise depends on our ability to …
Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model
Aims Acinetobacter baumannii causes severe nosocomial infections and is a difficult-to-treat
pathogen due to the development of multidrug-resistant (MDR) strains. Vaccines and …
pathogen due to the development of multidrug-resistant (MDR) strains. Vaccines and …